Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
India is set to consider to making the Advanced Emergency Braking Systems (AEBS) mandatory in…
Indian Space Research Organization (ISRO), the NVS-03 navigation satellite will be launched on October 30ht…
The Ajanta Caves, which are located inside a horseshoe-shaped gorge in Maharashtra, contain some of…
The Ministry of Communications, from the Department of Telecommunications (DoT) has notified the Telecommunications (Regulatory…
The 33rd edition of the bilateral maritime exercise between Singapore and India (SIMBEX-2026) commenced on…
Venerable folk artist Devadas Chimakode has won the prestigious annual honorary award of Karnataka Janapada…